Form 8-K Filing by Teleflex Incorporated

Teleflex Incorporated reported on March 17, 2026, regarding two separate transactions. The waiting period under the Hart-Scott-Rodino Antitrust Improvements Act (HSR Act) for the Original Equipment and Manufacturing and Development Services (OEM) transaction with Lotus US Bidco Inc. expired on March 13, 2026. This transaction is anticipated to close in the third quarter of 2026, subject to other regulatory approvals. For the Acute Care and Urology transaction with Intersurgical Limited, both parties received a Second Request from the U.S. Federal Trade Commission (FTC) on March 11, 2026. This extends the HSR Act waiting period until 30 days after substantial compliance with the Second Request. The closing of the Acute Care and Urology transaction is expected in the second half of 2026, pending regulatory approvals and other conditions. Both transactions can be consummated independently.